Literature DB >> 15770716

Comparison between combination therapy of percutaneous ethanol injection and radiofrequency ablation and radiofrequency ablation alone for patients with hepatocellular carcinoma.

Kazutaka Kurokohchi1, Seishiro Watanabe, Tsutomu Masaki, Naoki Hosomi, Yoshiaki Miyauchi, Takashi Himoto, Yasuhiko Kimura, Seiji Nakai, Akihiro Deguchi, Hirohito Yoneyama, Shuhei Yoshida, Shigeki Kuriyama.   

Abstract

AIM: In the present study, the characteristics of PEI-RFA treatment were further elucidated by analyzing the relationship between the volume of coagulated necrosis and the energy requirement for ablation or the amount of ethanol injected into HCC.
METHODS: The volume of coagulated necrosis, total energy requirement and energy requirement for coagulation of per unit volume were examined in the groups of PEI-RFA and RFA alone using the Cool-tip RF system.
RESULTS: The results showed that the volume of coagulated necrosis induced was significantly larger in PEI-RFA group than in routine RFA group, when the total energy administered was comparable in both groups. In PEI-RFA, enlargement of coagulated necrosis was admitted in 3 dimensions and the amount of energy requirement per unit volume of coagulated necrosis was negatively correlated with the amount of ethanol injected into HCC.
CONCLUSION: These results suggest that, compared to RFA alone, PEI-RFA enables to induce comparable coagulated necrosis with smaller energy requirement, and that PEI-RFA is likely to be less invasive than RFA alone irrespective of inducing enhanced coagulated necrosis. Thus, simple prior injection of ethanol may make RFA treatment more effective and less invasive for the treatment of patients with HCC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15770716      PMCID: PMC4305682          DOI: 10.3748/wjg.v11.i10.1426

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

1.  Percutaneous radiofrequency interstitial thermal ablation of small hepatocellular carcinoma.

Authors:  H P Allgaier; P Deibert; I Zuber; M Olschewski; H E Blum
Journal:  Lancet       Date:  1999-05-15       Impact factor: 79.321

2.  Enlargement of thermal ablation zone by the combination of ethanol injection and radiofrequency ablation in excised bovine liver.

Authors:  Seishiro Watanabe; Kazutaka Kurokohchi; Tsutomu Masaki; Yoshiaki Miyauchi; Toshiharu Funaki; Hideyuki Inoue; Takashi Himoto; Yuko Kita; Naohito Uchida; Tetsuo Touge; Toshiaki Tatsukawa; Shigeki Kuriyama
Journal:  Int J Oncol       Date:  2004-02       Impact factor: 5.650

3.  Percutaneous hot saline injection therapy for hepatic tumors: an alternative to percutaneous ethanol injection therapy.

Authors:  N Honda; Q Guo; H Uchida; H Ohishi; Y Hiasa
Journal:  Radiology       Date:  1994-01       Impact factor: 11.105

4.  Radiotherapy for large hepatocellular carcinoma combined with transcatheter arterial embolization and percutaneous ethanol injection therapy.

Authors:  S Yasuda; H Ito; M Yoshikawa; M Shinozaki; N Goto; H Fujimoto; K Nasu; T Uno; J Itami; K Isobe; N Shigematsu; M Ebara; H Saisho
Journal:  Int J Oncol       Date:  1999-09       Impact factor: 5.650

5.  Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis.

Authors:  S A Curley; F Izzo; L M Ellis; J Nicolas Vauthey; P Vallone
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

6.  Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients.

Authors:  L Solbiati; T Ierace; S N Goldberg; S Sironi; T Livraghi; R Fiocca; G Servadio; G Rizzatto; P R Mueller; A Del Maschio; G S Gazelle
Journal:  Radiology       Date:  1997-01       Impact factor: 11.105

7.  Radiofrequency thermotherapy for malignant liver tumors.

Authors:  Y Nagata; M Hiraoka; K Akuta; M Abe; M Takahashi; S Jo; Y Nishimura; S Masunaga; M Fukuda; H Imura
Journal:  Cancer       Date:  1990-04-15       Impact factor: 6.860

8.  Combination therapy of percutaneous ethanol injection and radiofrequency ablation against hepatocellular carcinomas difficult to treat.

Authors:  Kazutataka Kurokohchi; Seishiro Watanabe; Tsutomu Masaki; Naoki Hosomi; Toshiharu Funaki; Keiji Arima; Shuhei Yoshida; Seiji Nakai; Masayuki Murota; Yoshiaki Miyauchi; Shigeki Kuriyama
Journal:  Int J Oncol       Date:  2002-09       Impact factor: 5.650

9.  Clinical short-term results of radiofrequency ablation in liver cancers.

Authors:  Hong-Chi Jiang; Lian-Xin Liu; Da-Xun Piao; Jun Xu; Min Zheng; An-Long Zhu; Shu-Yi Qi; Wei-Hui Zhang; Lin-Feng Wu
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

10.  Radiofrequency ablation in the treatment of small hepatocellular carcinomas: comparison of the radiofrequency effect with and without chemoembolization.

Authors:  Mikiya Kitamoto; Masaru Imagawa; Hiroyasu Yamada; Chiyuki Watanabe; Masaaki Sumioka; Osamu Satoh; Masaru Shimamoto; Michiyo Kodama; Shojiro Kimura; Keiko Kishimoto; Yuzo Okamoto; Yasuhiko Fukuda; Kiyohiko Dohi
Journal:  AJR Am J Roentgenol       Date:  2003-10       Impact factor: 3.959

View more
  13 in total

1.  Percutaneous local therapies for hepatocellular carcinoma impair gastric function.

Authors:  Fumihiko Kinekawa; Kazuya Matsuda; Tsutomu Masaki; Kazutaka Kurokohchi; Hirohito Yoneyama; Hideyuki Inoue; Hirohide Kurata; Yoshihito Uchida; Seishiro Watanabe; Shigeki Kuriyama
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

Review 2.  Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status.

Authors:  Lumin Chen; Jihong Sun; Xiaoming Yang
Journal:  Cancer Lett       Date:  2015-10-22       Impact factor: 8.679

3.  Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma.

Authors:  Arne Dettmer; Timm-D Kirchhoff; Michael Gebel; Lars Zender; Nisar-P Malek; Bernhard Panning; Ajay Chavan; Herbert Rosenthal; Stefan Kubicka; Susanne Krusche; Sonja Merkesdal; Michael Galanski; Michael-P Manns; Joerg-S Bleck
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

4.  Successful treatment of advanced hepatocellular carcinoma by combined administration of 5-fluorouracil and pegylated interferon-alpha.

Authors:  Kazutaka Kurokohchi; Kouichi Takaguchi; Keiji Kita; Tsutomu Masaki; Shigeki Kuriyama
Journal:  World J Gastroenterol       Date:  2005-09-14       Impact factor: 5.742

5.  Evaluation of in vivo efficacy of radiofrequency ablation with D-sorbitol in animal liver.

Authors:  Asahiro Morishita; Teppei Sakamoto; Hideki Kobara; Tomoko Tadokoro; Kyoko Ohura; Koji Fujita; Joji Tani; Hisaaki Miyoshi; Hirohito Yoneyama; Takashi Himoto; Tsutomu Masaki
Journal:  Mol Clin Oncol       Date:  2015-11-16

6.  Influence of percutaneous local therapy for hepatocellular carcinoma on gastric function.

Authors:  Mitsuyoshi Kobayashi; Fumihiko Kinekawa; Kazuya Matsuda; Shintaro Fujihara; Noriko Nishiyama; Takako Nomura; Joji Tani; Hisaaki Miyoshi; Hideki Kobara; Akihiro Deguchi; Hirohito Yoneyama; Hirohito Mori; Tsutomu Masaki
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

7.  Successful treatment of hypovascular advanced hepatocellular carcinoma with lipiodol-targetting intervention radiology.

Authors:  Kazutaka Kurokohchi; Akihiro Deguchi; Tsutomu Masaki; Takashi Himoto; Hirohito Yoneyama; Mitsuyoshi Kobayashi; Tsuyoshi Maeta; Takaaki Kiuchi; Fumikazu Kohi; Hisaaki Miyoshi; Tomohiko Taminato; Shigeki Kuriyama
Journal:  World J Gastroenterol       Date:  2007-08-28       Impact factor: 5.742

8.  A combination therapy of ethanol injection and radiofrequency ablation under general anesthesia for the treatment of hepatocellular carcinoma.

Authors:  Kazutaka Kurokohchi; Seishiro Watanabe; Hirohito Yoneyama; Akihiro Deguchi; Tsutomu Masaki; Takashi Himoto; Hisaaki Miyoshi; Hamdy-Saad Mohammad; Akira Kitanaka; Tomohiko Taminato; Shigeki Kuriyama
Journal:  World J Gastroenterol       Date:  2008-04-07       Impact factor: 5.742

9.  Recent advances in radiofrequency ablation for the management of hepatocellular carcinoma.

Authors:  Takashi Himoto; Kazutaka Kurokohchi; Seishiro Watanabe; Tsutomu Masaki
Journal:  Hepat Mon       Date:  2012-10-10       Impact factor: 0.660

10.  Systematic evaluation of percutaneous radiofrequency ablation versus percutaneous ethanol injection for the treatment of small hepatocellular carcinoma: a meta-analysis.

Authors:  Rong-Hua Xu; Wei Gao; Chao Wang; De-Kai Guo; Lin Tang; Hui Zhang; Cong-Jun Wang
Journal:  Eur J Med Res       Date:  2014-08-20       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.